Document:

EX-10.7

 Exhibit 10.7 

PALADINA HEALTH, LLC 
 May 24,
2018 
 Christopher Miller 
  

	 	Re:	 Employment Agreement 

Dear Chris, 
 Paladina Health, LLC (the
“Company”) is pleased to offer you continued employment pursuant to the terms of this Employment Agreement (the “Agreement”). 

1. Effective Date; Term. This Agreement shall become effective upon the date of the closing of the transactions contemplated by that certain Securities
Purchase Agreement by and among DaVita DPC Holding Co. LLC, NEAPH Acquisitionco, Inc., Total Renal Care Inc. and DaVita Inc. (the “Purchase Agreement”, and such date of closing being the “Effective
Date”). Provided that this Agreement becomes effective, your period of employment hereunder shall be for the period from the business day immediately following the Effective Date until terminated pursuant to Section 3(g)
below (the “Term”). If the transactions contemplated by the Purchase Agreement do not close, this Agreement shall be void ab initio. Until the Effective Date, your employment will continue to be governed by your
October 26, 2015 offer of employment letter with the Company (the “Existing Offer Letter”), and on the Effective Date, this Agreement will supersede the Existing Offer Letter in its entirety and the Existing Offer
Letter will be of no further effect. You acknowledge and agree that this Agreement superseding the Existing Offer Letter will not trigger the severance obligation described in the Existing Offer Letter. 

2. Position. During the Term, you will serve as Chief Executive Officer of the Company and shall have such duties, authority and responsibilities as
are consistent with your position. You will report to and be a member of the Board of Managers (the “Board”) of NEAPH Holdings, LLC (“Parent”), the Company’s ultimate parent. If requested by the
Board, you shall serve as a director and/or executive officer of one or more other subsidiaries of the Company for no additional consideration. This is a full-time, overtime exempt position. During the Term, you will devote substantially all of your
business time and attention to the performance of your duties and you will not engage in any other business, profession, or occupation for compensation which would conflict or interfere with the performance of such services without the prior written
consent of the Board. Notwithstanding the foregoing, you will be permitted to act or serve as a director, trustee, committee member, or principal of any type of organization provided that such action or service does not constitute a conflict of
interest with your duties under this Agreement; provided that the same shall not interfere with your services to the Company as provided for herein or otherwise conflict with or result in a breach of Sections 5, 6 or 7 of
this Agreement. 
 3. Compensation, Benefits and Related Matters. 

(a) Base Salary. During the Term, the Company will pay you a base salary at the rate of $400,000.00 per annum, payable in accordance
with the Company’s standard payroll schedule. Your base salary in effect at any given time shall be referred to as the “Base Salary”. 

 (b) Annual Bonus. For each calendar year during the Term you will be eligible to earn
an annual performance cash bonus (each, an “Annual Bonus”). Your target Annual Bonus will equal to 75% of your Base Salary (as of the last day of the calendar year to which the Annual Bonus pertains), though the actual amount
of each Annual Bonus (if any) earned by you will be based on your and the Company’s achievement against applicable performance metrics (the “Bonus Performance Metrics”), to be established and determined by the Board in
its sole discretion. To receive your Annual Bonus for any particular calendar year during the Term, you must, in addition to achieving the applicable performance metrics, remain employed by the Company on the date the Annual Bonus is paid. 

1. Option to take Annual Bonus in Equity on Lieu of Cash. Within thirty (30) days of calculation of your earned Annual
Bonus for the applicable calendar year, you may elect to take equity securities of Parent (the “Parent Units”) in lieu of cash compensation for all or part of your Annual Bonus pursuant to the terms of this
Section 3(b)1. Any portion of your Annual Bonus which you elect to receive in Parent Units shall be granted to you in Parent Units having an aggregate fair market value as of the date such Annual Bonus would become payable (determined by
the Board (excluding you) in its good faith discretion) equal to the amount of your Annual Bonus; provided, that, you will be entitled to elect, in your sole discretion, to instead apply any portion of your Annual Bonus, up to an aggregate amount
equal to your then remaining and unfunded Executive Commitment, against your obligations in respect of the Equity Line, in which case you will receive Parent Units at the valuation set forth in, and subject to the terms of, the Equity Line. For
purposes hereof, the term “Equity Line” shall mean the equity commitment line that the Company shall implement together with New Enterprise Associates (“NEA”), and/or its affiliates, and other
potential investors, and the term “Executive Commitment” shall mean the amount of your funding commitment with respect to the Equity Line, as set forth in the definitive documents related thereto. All equity grants made
pursuant to this Section 3(b)1 shall be immediately vested, and shall not be subject to any repurchase, automatic buyback, forfeiture, termination or other similar provisions in the LLC Agreement or any other agreement. 

(c) Equity. Parent will make up to 30% of its total outstanding equity interests available for grants of equity-based awards to the
management team (the “Available Management Pool”), subject to vesting requirements set forth in the Award Agreement (as defined below). As CEO, you shall be entitled to receive 33% of the Available Management Pool (the
“CEO Profit Interests”). The CEO Profit Interests will be subject solely to a four (4) year vesting schedule (the “Vesting Period”), with 15% of each such class of CEO Profits Interests
vesting upon the Effective Date (the “Initially Vested Profits Interests”) and the remaining portion vesting thereafter in 48 equal monthly installments pursuant to an award agreement (“Award
Agreement”) and the limited liability company agreement of Parent (the “LLC Agreement”). The CEO Profit Interests will be subject to all other terms applicable set forth in the Award Agreement and LLC Agreement;
provided, however, that the Initially Vested Profits Interests shall not be subject to any repurchase, automatic buyback, forfeiture, termination or other similar provisions in the LLC Agreement or any other agreement. Upon the consummation of a
Change in Control (as defined below), 100% of the unvested CEO Profits Interests will accelerate and vest on such Change in Control; provided, that you remain continuously employed by the Company through the consummation of such Change in Control.

  
 2 

 (d) Reimbursement of Expenses. All reasonable out-of-pocket business expenses that are documented by you and incurred in performing your duties under this Agreement will be reimbursed in accordance with the Company’s standard policies and procedures
which will be at least as favorable to you as those in effect prior to the Effective Date. In addition, the Company agrees to pay up to $10,000 per year of your annual Young Presidents’ Organization (YPO) membership dues during the Term. 

(e) Employee Benefits. As an employee of the Company, you will be eligible to participate in the Company-sponsored benefits
generally made available to the Company’s executive employees which will be at least as favorable to you as the policy in effect prior to the Effective Date. In addition, you will be entitled to paid time off in accordance with the
Company’s paid time off policy, as in effect from time to time, which will be at least as favorable to you as the policy in effect prior to the Effective Date. 

(f) Indemnification. You and the Company agree to enter into a customary indemnification agreement pursuant to which, among
other things, the Company shall hold you harmless for your acts and/or conduct committed in the course and scope of your employment and/or service as an executive, officer, and/or director. The Company also agrees to obtain a D&O Insurance
policy. 
 (g) Additional Investment Rights. The Company agrees that you will also have the right to invest in Paladina alongside NEA
at a valuation and on terms made available to other co-investors under the Equity Line; provided, that the total amount of your investment shall be subject to the prior approval of the Board and NEA. 

4. Termination. Subject to the terms of this Section (g), your employment with the Company will be “at will,” meaning that
either you or the Company may terminate your employment at any time during the Term for no reason or for any reason not otherwise specifically prohibited by law, and any contrary representations that may have been made to you are superseded by this
Agreement. 
 (a) Compensation and Benefits Upon Termination Generally. If your employment with the Company is terminated for any
reason, the Company shall pay or provide to you your final accrued Base Salary, accrued but unused paid time off, reimbursement for reasonable documented business expenses, and any vested benefits you may have under the Company’s employee
benefit plans through the date of termination (collectively, the “Accrued Benefit”). 
 (b) Compensation and
Benefits Upon Termination by the Company without Cause or Termination by You for Good Reason. If your employment is terminated by the Company without Cause (defined below) or by you for Good Reason (defined below), then, in addition to the
Accrued Benefit and subject to you signing the Separation Agreement (defined below) and the Separation Agreement becoming effective within sixty (60) days of the date of such termination, the Company shall pay you the Severance Amount
(defined below) and provide you the Severance Benefits (as defined below). For the avoidance of doubt, your eligibility for the Severance Amount and Severance Benefits is in lieu of your eligibility for severance under any other agreement or plan
(including, without limitation, the Existing Offer Letter or the DaVita HealthCare Partners Inc. Severance Plan referenced therein). 

  
 3 

 (c) Definitions. For purposes of this Agreement, the following terms shall have the
following definitions: 
 “Cause” means (i) your willful or continuous failure to perform your duties (other
than any such failure resulting from incapacity due to physical or mental illness); (ii) your willful failure to comply with any valid and legal directive of the Board of Directors; (iii) either (A) indictment of a crime constituting a
felony in the relevant jurisdiction or (B) conviction of, or plea of guilty or nolo contendere to, a crime constituting a misdemeanor that would be reasonably expected to result in material injury (including reputational harm) to the Company
and its subsidiaries, taken as a whole; or (iv) your material violation of any of the Company’s material written employment policies. Except for a failure, breach, or refusal which, by its nature, cannot reasonably be
expected to be cured, you will have ten (10) business days from the delivery of written notice by the Company within which to cure any acts constituting Cause. 

“Good Reason” means the occurrence of any of the following, in each case during the Term without your written consent:
(i) a material reduction in your Base Salary (but not including any reductions made in a consistent manner for all or substantially all of the Company’s executives); (ii) a reduction in your target Annual Bonus opportunity set forth in
Section 3(b) above; (iii) a relocation of your principal place of employment by more than thirty (30) miles; (iv) any material breach by the Company of any material provision of this Agreement or of any other
agreement between you and the Company; and (v) a material adverse change to your title, authority, duties, or responsibilities (other than temporarily while you are physically or mentally incapacitated or as required by applicable law). Except
for a failure, breach, or refusal which, by its nature, cannot reasonably be expected to be cured, the Company will have ten (10) business days from the delivery of written notice by you within which to cure any acts constituting Good Reason.
Notwithstanding anything to the contrary herein, Good Reason shall not exist unless you provide notice of your intention to terminate your employment for Good Reason to the Company within 90 days of your initially becoming aware of the grounds for
such Good Reason. 
 “Change in Control” shall mean an Exit Event, as defined in the LLC Agreement. 

“Separation Agreement” means a separation agreement in a form reasonably satisfactory to you and to the Company
containing, among other customary provisions, a release of claims in favor of the Company and its related persons and affiliates, non-disparagement, and a reaffirmation of post-employment continuing
obligations to the Company, to the extent applicable. 
 “Severance Amount” shall mean an amount equal to
(A) twelve (12) months of your final Base Salary plus (B) your prorated Annual Bonus (calculated as the Annual Bonus that would have been paid for the entire calendar year multiplied by a fraction, the numerator of which is equal to the
number of days worked in the calendar year and the denominator of which is equal to the total number of days in such year) for the particular calendar year in which termination of your employment occurs, but only if the prorated Bonus Performance
Metric applicable to such Annual Bonus (calculated as the Bonus 

  
 4 

 
Performance Metric for the entire calendar year multiplied by a fraction, the numerator of which is equal to the number of days worked in the calendar year and the denominator of which is equal
to the total number of days in such year) is met as of the date of separation(“Bonus Severance”). When due under Section 4(b), the Severance Amount shall be paid out in substantially equal installments in
accordance with the Company’s payroll practice of twelve months commencing within sixty (60) days after the date of termination; provided, however, that if the 60-day period begins in
one calendar year and ends in a second calendar year, the Severance Amount shall begin to be paid in the second calendar year by the last day of such 60-day period; provided, further, that the
initial payment shall include a catch-up payment to cover amounts retroactive to the day immediately following the date of termination before the Separation Agreement became effective. The Severance Amount is
intended, and shall be interpreted, to: (x) comply with Section 409A of the Internal Revenue Code and the Treasury Regulations and other guidance promulgated thereunder; or (y) be exempt from Code Section 409A as a “short
term deferral,” within the meaning of Treas. Reg. Section 1.409A-1(b)(4), or as “separation pay,” within the meaning of Treas. Reg.
Section 1.409A-1(b)(9). In all events, this Agreement shall be interpreted and administered consistent with such intent. Each installment of the Severance Amount shall be treated as a separate payment for
purposes of Code Section 409A. For the avoidance of doubt, and notwithstanding anything to the contrary herein, any Bonus Severance to which you may become entitled shall not become due to you until such date as the Company pays its other
annual bonus obligations for such calendar year. 
 “Severance Benefits” means an amount equal to twelve
(12) months of the monthly premium you would have to pay for health continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985 (“COBRA”) for yourself and your dependents to continue to receive the same
coverage you received prior to your termination. 
 (d) Resignation from All Positions. Upon the termination of your employment with
the Company for any reason, you shall be deemed to have resigned, as of the date of such termination, from all positions you then hold as an officer, director, employee and member of the Board (and any committee thereof) of the Company and any of
its subsidiaries. 
 (e) Exclusive Remedy. The foregoing payments upon termination of your employment shall constitute the exclusive
payments due to you upon a termination of your employment under this Agreement. 
 (f) Cooperation. To the extent that such
obligations do not materially interfere with your subsequent employment, following the termination of your employment with the Company for any reason, you agree to reasonably cooperate with the Company upon reasonable request of the Board and to be
reasonably available to the Company with respect to matters arising out of your services to the Company and its subsidiaries on terms and for compensation to be reasonably agreed between you and the Company. The Company shall reimburse you for out-of-pocket expenses reasonably incurred in connection with such matters as agreed by you and the Board. 

  
 5 

 5. Covenant Not to Compete. You agree that during the Term and for the twelve (12) month
period following the termination of your employment for any reason (whether voluntary or involuntary) (“Restricted Period”), you shall not, as an employee, independent contractor, consultant, or in any other form, prepare to
provide or provide any of the same or similar services that you performed during your employment with the Company for any Competitor in the Restricted Geographic Area. You agree that during the Restricted Period you shall not own, manage, control,
operate, invest in, acquire an interest in, or otherwise act for, or act on behalf of any Competitor in the Restricted Geographic Area; provided, however, nothing in this Agreement will prohibit you from holding any investment contemplated by this
Agreement. You acknowledge and agree that the geographical limitations and duration of this covenant not to compete are reasonable. For purposes of this Agreement: 

(a) “Business” means any business that is predominantly focused on providing direct primary care to employees of
self-insured employers or municipalities or to members of unions. 
 (b) “Competitor” means any Person which
engages in the Business. 
 (c) “Person” means any individual, partnership, limited liability Company,
corporation, independent practice association, management services organization, clinic, proprietorship, firm, association or any other entity. 

(d) “Restricted Geographic Area” means the United States of America. 

6. Covenant Not to Solicit. You agree that, during the Restricted Period, you will not, directly or indirectly: (i) solicit for employment
or hire any person who is or was an employee of the Company or its subsidiaries as of the date that your employment terminated; provided, however, that you will not be prohibited from soliciting such employees who are contacted as a
result of use of general advertisements or other general non-targeted business recruitment techniques; or (ii) induce any patient, customer, independent contractor, consultant, vendor or supplier of the
Company or any physician (or former physician) affiliated with the Company or its subsidiaries (collectively, the “Restricted Parties”), in each case as of the date your employment terminated, to (x) enter into any
business relationship that would interfere with the business of the Company or its subsidiaries or (y) withdraw from, curtail or cancel such Restricted Party’s business relationship with the Company or its subsidiaries. 

7. Confidentiality. 
 (a) You
acknowledge and agree that: (i) during the course of employment by the Company, you will have access to and learn about confidential, secret, and proprietary documents, materials, customer and supplier lists, trade secrets, business plans,
budgets, data, and other information, in tangible and intangible form, of and relating to the Company (“Confidential Information”); (ii) this Confidential Information is of great competitive importance and commercial value to
the Company; and (iii) improper use or disclosure of the Confidential Information could cause irreparable harm to the Company. 
 (b)
You agree that you will treat all Confidential Information as confidential, safeguard such Confidential Information, and not disclose or make available any Confidential Information to anyone outside of the Company and its subsidiaries at any time or
use any such Confidential Information except in each case as required in the performance of your duties to the Company. 

  
 6 

 (c) You acknowledge and agree that these confidentiality obligations continue after
the termination of your employment until the Confidential Information has become public knowledge other than as a result of your breach of this Agreement. 

(d) You agree that all lists, materials, records, books, data, plans, files, reports, correspondence, and other documents
(“Company material”) used or prepared by, or made available to, you shall be and remain property of the Company. Upon termination of employment, you shall immediately return all Company material to the Company, and you shall
not make or retain any copies or extracts thereof. 
 (e) You acknowledge and agree that all Confidential Information, whether
created by you or another person, is the property of the Company and agree that, upon termination of your employment, you will return all such materials to the Company. 

(f) You acknowledge and agree that all work product that is developed or created by you in connection with the performance of your
duties as an employee of the Company is the sole property of the Company, and you hereby assign and/or agree to assign any such work product to the Company. 

8. Acknowledgements. 
 You acknowledge
that any breach of Sections 5, 6 or 7 of this Agreement by you will result in irreparable harm to the Company and that money damages will be inadequate and difficult to measure. Therefore, in addition to any
other remedy at law or equity available to the Company, you agree that the Company shall be entitled to seek temporary, preliminary, and permanent injunctive relief to prevent any actual or threatened breach or continuation of any such breach of
this Agreement, or to cure any such breach of this Agreement, without the necessity of proving actual damages or posting a bond or other security therefor. 

You acknowledge that the covenants and agreements herein, including Sections 5, 6 and 7 herein are
reasonable and necessary to protect the Company’s legitimate business interests. Nothing in Sections 5, 6 or 7 herein changes, alters, or modifies, in any way, the
at-will nature of your employment with the Company. 
 You acknowledge and agree that any
information, materials, ideas, discoveries, inventions, techniques, or programs developed, created, or discovered by you in connection with the performance of your duties as an employee of the Company shall be and remain the sole and exclusive
property of the Company, and you hereby assign and/or agree to assign any such information, materials, ideas, discoveries, inventions, techniques, or programs to the Company. You are hereby notified that the foregoing does not apply to an invention
that you create entirely on your own time, without the use of any equipment, supplies, facilities, or trade secret or confidential information of the Company. 

The Company shall have the right to make Sections 5, 6 or 7 of this Agreement known to any Competitor
with whom the Company reasonably believes you have become, or are about to become, associated, provided, however, the Company gives you at least ten (10) days’ notice of its intention to disclose any of the terms of this Agreement. 

  
 7 

 9. Miscellaneous. 

(a) Governing Law. This is a Colorado contract and shall be construed under and be governed in all respects by the laws of the
State of Colorado, without giving effect to the conflict of laws principles of such State. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be interpreted and applied by
the United States Court of Appeals for the Tenth Circuit. 
 (b) Consent to Jurisdiction. The parties hereby consent to the
jurisdiction of the state and federal courts situated nearest Denver, Colorado. Accordingly, with respect to any such court action, you (i) submit to the personal jurisdiction of such courts; (ii) consent to service of process; and
(iii) waive any other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process. 

(c) Taxes. All forms of compensation referred to in this Agreement are subject to reduction to reflect applicable withholding
and payroll taxes and other deductions required by law. 
 (d) Integration. This Agreement, together with the LLC Agreement,
the Award Agreement and any other plans or agreements referenced herein, constitutes the entire agreement between the parties with respect to the subject matter hereof and thereof, and supersedes all prior agreements between the parties concerning
such subject matter, including, without limitation, the Existing Offer Letter. To the extent this Agreement conflicts with any provision of any other plan or other agreement, including any noncompetition and/or nonsolicitation provisions in any
other agreement, whether or not incorporated herein by reference, this Agreement shall prevail and govern as to the conflicting provision(s) and with regard to the subject matter(s) of the conflicting provision(s). 

(e) Successors. This Agreement shall inure to the benefit of and be enforceable by your personal representatives, executors,
administrators, heirs, distributees, devisees and legatees. 
 (f) Enforceability. If any portion or provision of this
Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the
application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the
fullest extent permitted by law. 
 (g) Survival. The provisions of this Agreement shall survive the termination of this
Agreement and/or the termination of your employment to the extent necessary to effectuate the terms contained herein. 
 (h)
Waiver. No waiver of any provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party
of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. 

  
 8 

 (i) Notices. Any notices, requests, demands and other communications provided
for by this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to you at the last address
you have filed in writing with the Company or, to the Company, at its main offices, attention of the Board. 
 (j) Successors to
and Assigns of the Company. This Agreement, together with the other agreements, plans and documents referenced in Section 9(d), shall inure to the benefit and be enforceable by the Company’s successors and assigns. 

(k) Amendment. This Agreement may be amended or modified only by a written instrument signed by you and by a duly authorized
representative of the Company. 
 (l) Counterparts. This Agreement may be executed in any number of counterparts, each of
which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document. 

[signature page follows] 

  
 9 

 To accept this Agreement, please sign and return it to the Board by no later than the Effective Date. 

 

	
	Very truly yours,
	
	PALADINA HEALTH, LLC
	
	/s/ John Do
	Name: John Do
	Title: Vice President, Finance
	
	NEAPH Holdings, LLC
	Parent Company
	
	/s/ Mohamad Makhzoumi
	Mohamad Makhzoumi
	President

  

	
	I have read and accept this Agreement:
	
	/s/ Christopher T. Miller
	Christopher T. Miller
	
	5/23/18
	Date

  
 10EX-10.8

 Exhibit 10.8 

EMPLOYMENT AGREEMENT 

This Employment Agreement (this “Agreement”) is made effective as of October 18, 2018 (the “Effective Date”), by and
between Paladina Health, LLC (“Employer”) and Tobias Barker, MD (“Employee”). 
 In consideration of the mutual
covenants and agreements hereinafter set forth and for other good and valuable consideration, the parties hereto, intending to be legally bound hereby, agree as follows: 

Section 1. Employment and Duties. Employer hereby employs Employee to serve initially as Chief Medical Officer of Paladina
Health, LLC (“CMO” of “Paladina”). Employee accepts such employment on the terms and conditions set forth in this Agreement. Employee shall perform the duties of CMO, or any additional or different duties or jobs as
the Employer deems appropriate. Employee shall work out of the Denver home office of Paladina. Employee agrees to devote substantially all of his time, energy, and ability to the business of Employer on a full-time basis and shall not engage in any
other business activities during the term of this Agreement, including but not limited to providing consulting services, provided however, Employee may pursue normal personal and charitable activities so long as such activities do not
require a substantial amount of time and do not interfere with his ability to perform his duties. Employee shall at all times observe and abide by the Employer’s policies and procedures as in effect from time to time. In order to comply with
the various state CPOM laws and regulations Employee understands that he may be required to obtain a medical license in the states Employer conducts business in, both now and in the future. Employee likewise may be required to take ownership of
certain medical groups that employ the medical professionals who provide direct primary care services for Employer’s clients’ employees and dependents. The costs associated with obtaining Employee’s licenses shall be borne by
Employer. 
 Section 2. Compensation. In consideration of the services to be performed by Employee hereunder, Employee
shall receive the following compensation and benefits: 
 2.1 Base Salary. Employer shall pay Employee a base salary of $ 300,000.00
per annum, less standard withholdings and authorized deductions. Employee shall be paid consistent with Employer’s payroll schedule. The base salary will be reviewed from time to time. Employer, in its sole discretion, may increase the base
salary as a result of any such review. Employer may not reduce Employee’s base salary unless the Employee authorizes it in writing or the Employer is reducing the base salary of other similarly-situated executives by a similar percentage. 

2.2 Benefits. Employee and his family, if applicable, shall be eligible for participation in and shall receive all benefits under
Employer’s health and welfare benefit plans (including, without limitation, medical, prescription, dental, disability, and life insurance) under the same terms and conditions applicable to most executives at similar levels of compensation and
responsibility. 

 2.3 Annual Discretionary Performance Bonus. 

(a) In 2018, Employee shall be eligible to receive a discretionary performance bonus (the “Bonus”) between zero and S 35,000,
payable in a manner consistent with Employer’s practices and procedures and as part of and during the Employer’s bonus cycle. Commencing in 2019, Employee shall be eligible to receive a discretionary performance bonus between zero and $
150,000.00. The amount of the respective Bonuses, if any, will be decided by the CEO and the Board of Directors. 
 (b) In deciding on the
amount of the annual discretionary performance bonuses, if any, the CEO and the Board of Directors may consider the competitive market for the services provided by employees who are performing the same or similar duties as Employee is providing
Employer and who have similar background and experience. 
 (c) Employee must be employed by Employer on the date any Bonus is paid to be
eligible to receive such Bonus and, if Employee is not employed by Employer (or an affiliate) on the date any Bonus is paid for any reason whatsoever, Employee shall not be entitled to receive such Bonus. 

2.4 Paid Time Off. Employee shall have paid time off, subject to the approval of the CEO. 

2.5 Value Units Award. Subject to approval ty the Employer’s Board of Directors, Employee will receive an equity-based award which
award will be structured as profits interests in the Employer. Upon approval of the Board of Directors Employer shall award to Employee: 369,444.44 Value A Units, 217,320.26 Value B Units 378,557.87 Value C Units and, 459,677.42 Value D Units,
subject to all of the terms and Conditions of the separately provided Award Agreement. Subject to the terms and conditions of the Award Agreement twenty-five percent (25%) of each class of the Value Units granted to Employee herein shall vest on the
first anniversary of your first date of employment (the “Vesting Commencement Date” and “issue Date”), with the remaining portion of each class of such Value Units vesting thereafter in thirty-six (36) substantially
equal monthly installments such that one-hundred percent (100%) of each class of the Value Units granted as of the Issue Date shall become fully vested on the fourth anniversary of the Vesting Commencement
Date. For the avoidance of doubt, the foregoing vesting schedule requires the continued employment of Employee by Employer through each applicable vesting date as a condition to the vesting of the applicable installment of the Value Units granted
herein. (See performance Schedule attached to this Employment Agreement for further explanation). 
 2.6 Indemnification. Employer
agrees to indemnify Employee against and in respect of any and all claims, actions, or demands, to the extent permitted by the Employer’s Bylaws and applicable law. 

2.7 Reimbursement. Employer also agrees to reimburse Employee in accordance with Employer’s reimbursement policies for travel and
entertainment expenses, as well as other reasonable business-related expenses, incurred in the performance of his duties hereunder. 

 2.8 Changes to Benefit flans. Employer reserves the rights to modify, suspend, or
discontinue any and all of its health and welfare benefit plans, practices, policies, and programs at any time without recourse by Employee so long as such action is taken generally with respect to all other similarly-situated peer executives and
does not single out Employee. 
 Section 3. Provisions Relating to termination of Employment. 

3.1 Termination for Material Cause. Employer may terminate Employee’s employment without advance notice for Material Cause (as
defined below). Upon termination for Material Cause, Employee shall (i) be entitled to receive the Base Salary and benefits as set forth in Section 2.1 and Section 2.2, respectively, through the effective date of such
termination and (ii) not be entitled to receive any other compensation, benefits, or payments of any kind, except as otherwise required by law or by the terms of any benefit or retirement plan or other arrangement that would, by its
terms, apply. 
 3.2 Employee Resignation. Employee may resign from Employer For Cause (as defined below) upon at least thirty
(30) days’ advance written notice. If Employee resigns from Employer, Employee shall (i) be entitled to receive the base salary and benefits as set forth in Section 2.1 and Section 2.2,
respectively, through the effective date of such termination, and (ii) not be entitled to receive any other compensation, benefits, or payments of any kind, except as otherwise required by law or by the firms of any benefit or retirement
plan or other arrangement that would, by its terms, apply. In the event Employee resigns from Employer, Employer shall have the right to make such resignation effective as of any date before the expiration of the required notice period. “Fair
Cause” as used in this paragraph shall mean a material breach by Employer of any of the terms set forth in this Agreement or a material demotion or substantial and material change in Employee’s role and duties. 

3.3 Termination Without Cause. It is understood and agreed that cither you or Employer may terminate this relationship at any time, for
any or no reason, upon ninety (90) days’ prior written notice to the non- terminating party. In the event that your employment is terminated without cause by Employer you will be eligible to
receive salary continuation for a period of three (3) months (“Severance Period”). This salary continuation is subject to mitigation and/or offset if you find alternative employment during the Severance Period, and also is
contingent on your agreement to Employer’s standard release agreement, which includes a full release of claims against Employer. 
 3.4
Disability. Upon thirty (30) days’ advance notice (which notice may be given before the completion of the periods described herein), Employer may terminate Employee’s employment for Disability (as defined below). 

3.5 Definitions. For the purposes of this Agreement, the following terms shall have the meanings indicated: 

(a) “Disability” shall mean the inability, for a period of six (6) months, to adequately perform Employee’s
regular duties, with or without reasonable accommodation, due to a physical or mental illness, condition, or disability. 

 (b) “Material Cause “ shall mean any of the following: (i) conviction
of a felony or plea of no contest to a felony; (ii) any act of fraud or dis honesty in connection with the performance of his duties; (iii) repeated failure or refusal by Employee to follow policies or directives reasonably
established by the Chief Executive Officer of Employer or his designee that goes uncorrected for a period of ten (10) consecutive days after written notice has been provided to Employee; (iv) a material brei.ch of this
Agreement; (v) any gross or willful misconduct or gross negligence by Employee in the performance of his duties; (vi) egregious conduct by Employee that brings Employer or any of its subsidiaries or affiliates into public
disgrace or disrepute; (vii) an act of unlawful discrimination, including sexual harassment; (viii) a violation of the duty of loyalty or of any fiduciary duty; or (ix) exclusion or notice of exclusion of Employee
from participating in any federal health care program. 
 3.6 Notice of Termination Any purported termination of Employee’s
employment by Employer or by Employee shall be communicated by a written Notice of Termination to the other party hereto in accordance with Section 5.4 hereof. A “Notice of Termination” shall mean a written notice that indicates the
specific termination provision in this Agreement. 
 3.7 Effect of Termination. Upon termination, this Agreement shall be of no
further force and effect and neither party shall have any further right or obligation hereunder; provided, however, that no termination shall modify or affect the rights and obligations of the parties that have accrued prior to termination; and
provided further, that the rights and obligations of the parties under Section 3, Section 4, and Section 5 shall survive termination of this Agreement. 

Section 4. Non-Solicitation, Non-Competition and Confidentiality. Employee,
contemporaneously herewith, shall enter into a Non-Solicitation, Non-Competition and Confidentiality Agreement, the terms of which are incorporated herein and made a
part hereof as though set forth in this Agreement. 
 Section 5. Miscellaneous. 

5.1 Entire Agreement: Amendment. This Agreement represents the entire understanding of the parties hereto with respect to the
employment of Employee and supersedes all prior agreements with respect thereto. Thin Agreement may not be altered or amended except in writing executed by both parties hereto. 

5.2 Assignment; Benefit. This Agreement is personal and may not be assigned by Employee. This Agreement ma / be assigned by Employer
and shall inure to the benefit of and be binding upon the successors and assigns of Employer. 
 5.3 Applicable Law; Venue. This
Agreement shall be governed by the laws of the State of Colorado, without regard to the Manciples of conflicts of laws. Both parties agree that any action relating to this Agreement shall be brought in a state or federal court of competent
jurisdiction located within the City and County of Denver, State of Colorado and both parties agree to exclusive venue within the City and County of Denver, State of Colorado. 

 5.4 Notice. Notices and all other communications provided for in this Agreement shall
be In writing and shall be deemed to have been duly given when delivered or mailed by United States registered mail, return receipt requested, postage prepaid, addressed to Employer at its principal office and to Employee at Employee’s
principal residence as shown in Employer’s personnel records, provided that all notices to Employer shall be directed to the attention of the Chief Executive Officer, or to such other address as cither party may have furnished to the other in
writing in accordance herewith, except that notice of change of address shall be effective only upon receipt. 
 5.5 Construction.
Each party has cooperated in the drafting and preparation of this Agreement. Hence, in any construction t) be made of this Agreement, the same shall not be construed against any party on the basis that the party was the drafter. The captions of this
Agreement are not part of the provisions hereof and shall have no force or effect. 
 5.6 Execution. This Agreement may be executed
in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Photographic or facsimile copies of such signed counterparts may be used in lieu of the originals for any
purpose. 
 5.7 Legal Counsel. Employee and Employer recognize that this is a legally binding contract and acknowledge and agree that
they have had the opportunity to consult with legal counsel of their choice. 
 5.8 Waiver. The waiver by any party of a breach of
any provision of this Agreement by the other shall not operate or be construed as a waiver of any other or subsequent breach of such or any provision. 

5.9 Invalidity of Provision, In the event that any provision of this Agreement is determined to be illegal, invalid, or void for any
reason, the remaining provisions hereof shall continue in full force and effect. 
 5.10 Approval by Paladino Health, LLC as to Form.
The parties acknowledge and agree that this Agreement shall take effect and be legally binding upon the parties only upon full execution hereof by the parties and upon approval by Paladina Health, LLC as to the form of hereof. 

 IN WITNESS WHEREOF, the parties hereto have entered into this Agreement effective as of the
date and year first written above. 
  

									
	 PALADINA HEALTH, LLC
	 		 	Tobias Barker, MD
					
	By:	 	 /s/ Chris Miller
	 		 	By:	 	 /s/ Tobias Barker

					
	Date:	 	 9/17/18
	 		 	Date:	 	 9/18/18

				
	Approved as to Form:	 		 		 	
				
	 /s/ Gregory J. Mayers
	 		 		 	
	Gregory J. Mayers	 		 		 	
	General Counsel Paladina Health, LLC	 		 		 	

 PERFORMANCE SCHEDULE 

Upon the consummation of an Exit Event (as will be defined in the operating agreement of Holdings) such Profits Interests (assuming that they are fully vested
at such time) shall entitle the holders to the percentages of the proceeds received by equity holders of Holdings from an Exit Event (the “Equity Proceeds”) in accordance with the following performance schedule: 

 

	 	•	 	 Value A: upon an Exit Evert yielding a lx return to the equity investors, (collectively, the
“Investors”), for their aggregate equity investment in Holdings on or after the Effective Date (“Investment”), holders of Profits Interests will share in up to 10.00% of Equity Proceed:; in excess of the lx return to Investors;

  

	 	•	 	 Value B: upon an Exit Event yielding a 2x return ;o the Investors from their Investment, holders of Profits
Interests will share in up to 15.00% of Equity Proceeds in excess of the 2x return to Investors; 

  

	 	•	 	 Value C: upon an Exit Event yielding a 3x return to the Investors from their Investment, holders of Profits
Interests will share in up to 22.50% of Equity Proceeds in excess of the 3x return to Investors; and 

  

	 	•	 	 Value D: upon an Exit Event yielding a 4x return to the Investors from their Investment, holders of Profits
Interests will share in up to 30.00% of Equity Proceeds in excess of the 4x return to Investors. 

 The exact percentage of Holding’s
equity interests that the Profits Interests will constitute, and the amount of proceeds such Profits Interests will entitle you to receive upon the consummation of an Exit Event, is subject to the total amount of dollars Invested in Holdings as
equity, the determination by the Board of various performance thresholds, the issuance of other grants and other Issues that may arise from time to time. Once vested, all Profits Interests will fully participate in dividends and distributions made
by Company to its Investors pro rata on a fully- diluted basis. 
 Note: All binding terms and conditions around any award shall be set forth in the
separately provided Award Agreement and that document controls as to such award. 

 NONCOMPETITION, NONSOLICITATION, 

AND CONFIDENTIALITY AGREEMENT 

Paladina Health, LLC (“Employer”) and Tobias Barker, MD, (“Teammate”) enter into this Noncompetition, Nonsolicitation, and
Confidentiality Agreement (this “Agreement”) on this 18th day of September, 2018, the terms of which are set forth below. 

WHEREAS, Employer operates national y in a highly competitive environment; 

WHEREAS, Teammate agrees that by virtue of employment with Employer, Teammate will gain special knowledge and familiarity with the needs and
requirements of customers and business partners and that but for Teammate’s employment, Teammate would not have had access to such customers and business partners; 

WHEREAS, Employer will provide Teammate with confidential information, including, but not limited to, Information or data in any form or
medium, which has commercial or economic value to Employer, such as information regarding other employees, intellectual properly, processes, competitive data, contracts, licenses, customer lists, financial information, pricing structures or
guidelines, methods of operation, manuals, software and marketing plan; and strategies; 
 WHEREAS, Teammate recognizes that future success
at Employer is dependent on continuing to receive such sensitive and confidential information; and 
 THEREFORE, the parties agree as
follows: 
 1. Employer considers Teammate to be an integral part of its team, and Teammate acknowledges that Teammate has duties consistent
with such team. 
 2. In consideration for the covenants set forth herein, Employer is offering employment to Teammate, will provide
Teammate with the benefits set forth in the Teammate’s offer of employment, which is incorporated herein by reference, and will provide Teammate with confidential information. 

3. Covenant Not to Compete: (a) Teammate agrees that during the term of employment and for the twelve-month period following the
termination of employment for any reason (whether voluntary or involuntary) (“Restricted Period”), Teammate shall not, as an employee, independent contractor, consultant, or in any other form, prepare to provide or provide any of the same
or similar services that Teammate performed during employment with Employer for any Competitor in the Restricted Geographic Area. “Competitor” means any Person which engages in the Business. “Person” means any individual,
partnership, limited liability Company, corporation, independent practice association, management services organization, clinic, proprietorship, firm, association or any other entity. “Business” means the business of creating and
maintaining Direct Primary Care practice environments, managing the conversion of physician practices into Direct Primary Care retail practice environments, and establishing, operating and delivering Direct Primary Care practice environments
directly to employees on behalf of their public, private and government employers, unions and associations. The “Restricted Geographic Area” is the continental United States where Teammate works for Employer, or a smaller geographic area
if applicable per state law. “Direct Primary Care” means the provision of comprehensive primary healthcare services to patients for a recurring fee rather than individually itemized fixed fees for service for primary care services. 

 (a) Teammate agrees that during the Restricted Period, Terminate shall not own, manage,
control, operate, invest in, acquire an interest in, or otherwise act for, or det on behalf of any Competitor in the Restricted Geographic Area. 

(b) Teammate acknowledges am agrees that the geographical limitations and duration of this covenant not to compete are reasonable. 

4. Covenant Not to Solicit: Teammate agrees that during the Restricted Period, Teammate shall not (i) solicit any of
Employer’s employees to work for any Person; (ii) hire any of Employer’s employees to work (as an employee or an independent contractor) for any Person; (iii) take any action that may reasonably result in any of Employer’s
employees going to work (as an employee or an independent contractor) for any Person; (iv) induce any patient or customer of Employer, either individually or collectively, to patronize any Competitor or primary care clinic that competes with
primary care clinics managed or operated by Employer; (v) request or advise any patient, customer, or supplier of Employer to withdraw, curtail, or cancel such person’s business with Employer or primary care clinics managed by Employer;
(vi) enter into any contract the purpose or result of which would benefit Teammate if any patient or customer of Employer were to withdraw, curtail, or cancel such person’s business with Employer; (vii) solicit, it duce, or encourage
any physician (or former physician) affiliated with Employer or induce or encourage any other person under contract with Employer to curtail or terminate such person’s affiliation or contractual relationship with Employer; or
(viii) disclose to any Person the names or addresses of any patient or customer of Employer. 
 5. Confidentiality:
(a) Teammate acknowledges and agrees that: (i) in the course of his employment by Employer, it will or may be necessary for Teammate to create, use, or have access to technical, business, or customer information, materials, or data
relating to Employer’s present or planned business that has not been released to the public with Employer’s authorization, including, but not limited to, confidential information, materials, or proprietary data belonging to Employer or
relating to Employer’s affairs (collectively, “Confidential Information”) that come into Teammate’s possession by reason of employment with Employer; (ii) all Confidential Information is the property of Employer;
(iii) the use, misappropriation, or disclosure of any Confidential Information would constitute a breach of trust and could cause serious and irreparable injury lo Employer; and (iv) It is essential to the protection of Employer’s goodwill
and maintenance of Employer’s competitive position that all Confidential Information be kept confidential and that Team: rate not disclose any Confidential Information to others or use Confidential Information to Teammate’s own advantage
or the advantage of others. 
 (b) In recognition of the acknowledgment contained in Section 5(a) above, Teammate agrees that until the
Confidential Information becomes publicly available (other than through a breach by Teammate or by anyone else who has a legal obligation to maintain confidentiality), Teammate shall: (i) hold and safeguard all Confidential Information in trust
for Employer and its successors and assigns; (ii) not appropriate or disclose or maw available to anyone for use outside of Employer’s organization at any time, either during employment with

 
Employer or subsequent to the termination of employment with Employer for any reason, any Confidential Information, whether or not developed by Teammate, except as required in the performance of
Teammate’s duties to Employer; (iii) keep in strictest confidence any Confidential Information; (Iv) no disclose or divulge, or allow to be disclosed or divulged by any person within Teammate’s control, to any person, firm, or
corporation, or use directly or indirectly, for Teammate’s own benefit or the benefit of others, any Confidential Information; and (v) not become employed by or enter into service with any Person in which Teammate will be obligated to
disclose or use any trade secrets of Employer, or where such disclosure would be inevitable because of the nature of the position. 
 (c)
Teammate agrees that all lists, materials, records, books, data, plans, files, reports, correspondence, and other documents (“Company material”) used or prepared by, or made available to, Teammate shall be and remain property of Employer.
Upon termination of employment, Teammate shall immediately return all Company material to Employer, and Teammate shall not make or retain any copies or extracts thereof. 

(d) Teammate also agrees that Teammate will not provide advice to any Person concerning Confidential Information of Employer. Teammate further
agrees that if Teammate were to provide advice to any Person concerning the negotiation of any agreements with Employer or if Teammate were to negotiate any agreements on behalf of any Person with Employer, such advice and/or negotiations would
involve the inevitable disclosure of Confidential Information. 
 (e) Teammate further agree s that during the Restricted Period, employment
with Employer and for a one-year period following the termination of Teammate’s employment for any reason (voluntary or involuntary), Teammate shall net conduct or accept business with any of
Employer’s suppliers, vendors or customers who had been suppliers, vendors or customers within the twelve months preceding the date of the termination of Teammate’s employment and with whom Teammate had contact (“contact” being
defined as personal (as opposed to merely supervisory or incidental) interaction between Teammate and the supplier, vendor, or customer that takes place to farther the business relationship for or receive services from the supplier, vendor, or
customer) during Teammate’s term of employment with Employer. 
 (f) Teammate shall confirm, in writing, that Teammate is complying
with the terms of this provision In response to any Inquiry by Employer. 
 6. Teammate acknowledges that any breach of this Agreement by
Teammate will result in irreparable harm to Employer and that money damages will be inadequate and difficult to measure. Therefore, in addition to any other remedy at law or equity available to Employer, Teammate agrees that Employer shall be
entitled to temporary, preliminary, and permanent injunctive relief to prevent any actual or threatened breach or continuation of any breach of this Agreement, or to cure any breach of this Agreement, without the necessity of proving actual damages
or posting a bond or other security therefor. 
 7. Teammate acknowledges that the covenants and agreements herein are reasonable and
necessary to protect Employer’s legitimate business interests. The waiver by any party of a breach of any provision of this Agreement by the other shall not operate or be construed as a waiver of any other or subsequent breach of such or any
provision. 

 8. Teammate agrees that any information, materials, ideas, discoveries, inventions,
techniques, or programs developed, created, or discovered by Teammate in connection with the performance of Teammate’s duties as an employee of Employer shall be and remain the sole and exclusive property of Employer, and Teammate hereby
assigns and/or agrees to assign any such information, materials, ideas, discoveries, inventions, techniques, or programs to Employer. Teammate is notified that the foregoing does not apply to an invention that Teammate creates entirely on
Teammate’s own time, without the use of any equipment, supplies, facilities, or trade secret information of Employer. 
 9. Teammate
shall make the terms and conditions of this Agreement known to any Competitor with which Teammate becomes associated subsequent to the termination of employment with Employer and before Teammate’s association with such. Employer shall have the
right to make the terms of this Agreement known to any Competitor with whom Employer reasonably believes Teammate has become, or is about to become, associated. 

10. If any provision of this Agreement shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other
provision hereof. If a court determines that any restriction herein is invalid or unenforceable, the court is hereby requested, directed, and authorized (to the extent allowable under applicable state law) to revise such restrictions to include the
maximum restrictions allowed under applicable law; or if required by applicable law ignore the invalid or unenforceable provisions and apply the remainder of the Agreement. 

11. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Colorado (without regard to
principles of conflicts of laws). 
 12. This Agreement is personal and may not be assigned by Teammate. This Agreement may be assigned by
Employer and shall inure to the benefit of and be binding upon the successors and assigns of Employer. In addition, the covenants and acknowledgements of Teammate as set forth herein shall inure to the benefit of any successors to Employer and shall
survive the termination of this Agreement, regardless of cause, except if Employer ceases operation other than as a result of a change of control. 

13. Each party has cooperated In the drafting and preparation of this Agreement. Hence, in any construction to be made of this Agreement, he
same shall not be construed against any party on the basis that the party was the drafter. 
 14. The parties acknowledge and agree that
this Agreement shall take effect and be legally binding upon the parties upon full execution hereof by the parties. 

 IN WITNESS WHEREOF, Employer and Teammate executed this Agreement as of the day and year
first above written. 
  

							
	TEAMMATE	 		 	PALADINA HEALTH, LLC
			
	/s/ Tobias Barker	 		 	 /s/ Chris Miller

		 		 	Name:	 	Chris Miller
		 		 	Title:	 	CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]